Does PEGCETACOPLAN Cause Breakthrough haemolysis? 67 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Breakthrough haemolysis have been filed in association with PEGCETACOPLAN (Empaveli). This represents 4.9% of all adverse event reports for PEGCETACOPLAN.
67
Reports of Breakthrough haemolysis with PEGCETACOPLAN
4.9%
of all PEGCETACOPLAN reports
1
Deaths
18
Hospitalizations
How Dangerous Is Breakthrough haemolysis From PEGCETACOPLAN?
Of the 67 reports, 1 (1.5%) resulted in death, 18 (26.9%) required hospitalization.
Is Breakthrough haemolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGCETACOPLAN. However, 67 reports have been filed with the FAERS database.
What Other Side Effects Does PEGCETACOPLAN Cause?
Fatigue (135)
Visual impairment (125)
Haemoglobin decreased (106)
Haemolysis (100)
Off label use (97)
Vitreous floaters (78)
Headache (66)
Product dose omission issue (59)
Uveitis (59)
Covid-19 (56)
What Other Drugs Cause Breakthrough haemolysis?
Which PEGCETACOPLAN Alternatives Have Lower Breakthrough haemolysis Risk?
PEGCETACOPLAN vs PEGFILGRASTIM
PEGCETACOPLAN vs PEGFILGRASTIM-APGF
PEGCETACOPLAN vs PEGFILGRASTIM-BMEZ
PEGCETACOPLAN vs PEGFILGRASTIM-CBQV
PEGCETACOPLAN vs PEGFILGRASTIM-JMDB